Isabella Eckerle
Overview
Explore the profile of Isabella Eckerle including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
101
Citations
4141
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kodama C, Alhilfi R, Aakef I, Khamasi A, Mahdi S, Hasan H, et al.
Eur J Public Health
. 2025 Jan;
35(Supplement_1):i6-i13.
PMID: 39801332
Crimean-Congo hemorrhagic fever (CCHF) is an acute tick-borne disease with a case fatality rate of up to 40% in humans, posing a significant health threat. This study investigates the 2022-23...
2.
Nesbitt R, Kinya Asilaza V, Alvarez C, Gitahi P, Nkemenang P, Duncker J, et al.
Lancet Infect Dis
. 2025 Jan;
PMID: 39798583
Background: Hepatitis E virus (HEV) is a leading cause of acute viral hepatitis, particularly in Asia and Africa, where HEV genotypes 1 and 2 are prevalent. Although a recombinant vaccine,...
3.
Brangel P, Tureli S, Muhlemann B, Liechti N, Zysset D, Engler O, et al.
Viruses
. 2025 Jan;
16(12).
PMID: 39772242
Setting up a global SARS-CoV-2 surveillance system requires an understanding of how virus isolation and propagation practices, use of animal or human sera, and different neutralisation assay platforms influence assessment...
4.
Emperador D, Kelly-Cirino C, Bausch D, Eckerle I
Diagn Microbiol Infect Dis
. 2024 Oct;
111(1):116568.
PMID: 39467415
We conducted a systematic review and meta-analysis of studies and reports comparing the performance of antigen rapid diagnostic tests (Ag RDT) for diagnosing Ebola disease (EVD). We searched PubMed, EMBASE,...
5.
Muhlemann B, Wilks S, Baracco L, Bekliz M, Carreno J, Corman V, et al.
Sci Transl Med
. 2024 May;
16(747):eadl1722.
PMID: 38748773
The evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) requires ongoing monitoring to judge the ability of newly arising variants to escape the immune response. A surveillance system necessitates...
6.
Chedid M, Hentzien M, Eckerle I, Fedeli C, Calmy A
Rev Med Suisse
. 2024 Apr;
20(869):756-763.
PMID: 38616687
Immunosuppressed persons are a heterogeneous population that represents approximately 3 % of the adult population. They are more vulnerable to infectious agents, such as SARS-CoV-2. This is reflected by a...
7.
Essaidi-Laziosi M, Perez-Rodriguez F, Alvarez C, Sattonnet-Roche P, Torriani G, Bekliz M, et al.
Virus Res
. 2024 Feb;
339:199255.
PMID: 38389324
SARS-CoV-2's genetic plasticity has led to several variants of concern (VOCs). Here we studied replicative capacity for seven SARS-CoV-2 isolates (B.1, Alpha, Beta, Gamma, Delta, Zeta, and Omicron BA.1) in...
8.
Puhach O, Bellon M, Adea K, Bekliz M, Hosszu-Fellous K, Sattonnet P, et al.
EBioMedicine
. 2023 Nov;
98:104893.
PMID: 38035462
Background: Mucosal antibodies play a key role in the protection against SARS-CoV-2 infection in the upper respiratory tract, and potentially in limiting virus replication and therefore onward transmission. While systemic...
9.
Muhlemann B, Wilks S, Baracco L, Bekliz M, Carreno J, Corman V, et al.
bioRxiv
. 2023 Oct;
PMID: 37808679
The antigenic evolution of SARS-CoV-2 requires ongoing monitoring to judge the immune escape of newly arising variants. A surveillance system necessitates an understanding of differences in neutralization titers measured in...
10.
Flahault A, Calmy A, Costagliola D, Drapkina O, Eckerle I, Larson H, et al.
Lancet
. 2023 May;
401(10392):1909-1912.
PMID: 37230103
No abstract available.